|
Market Closed -
Sao Paulo
13:23:04 2026-07-28 EDT
|
5-day change | 1st Jan Change | ||
| 172.75 BRL | +1.41% |
|
-.--% | +7.30% |
| 08-13 | Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.30% | -0.26% | +19.10% | +15.42% | +4.41% | +38.86% | +1.15% | +24.48% | +95.77% | 80.23B | |
| -1.02% | -0.51% | +10.89% | +9.09% | -8.67% | -2.54% | +28.91% | +2.42% | - | 50.64B | |
| +1.46% | -4.31% | -9.99% | -9.11% | -9.72% | +11.90% | +164.55% | +118.59% | +197.43% | 46.87B | |
| +17.61% | +17.64% | +28.28% | +64.40% | -8.38% | -41.70% | -41.32% | -46.91% | +42.72% | 46.34B | |
| -0.32% | +0.98% | +1.53% | +8.40% | +18.84% | +50.90% | -20.02% | -40.21% | -33.35% | 31B | |
| +1.80% | +7.77% | +4.27% | +31.44% | +118.58% | +130.05% | -39.33% | -83.96% | - | 25.28B | |
| +2.78% | +1.60% | +5.33% | +29.58% | +25.04% | +42.08% | +92.34% | +63.23% | +61.48% | 24.36B | |
| +1.65% | +0.53% | +1.22% | +16.28% | +25.05% | -2.21% | +190.26% | +31.97% | - | 20.81B | |
| +3.95% | +1.02% | -1.72% | +3.81% | +37.56% | +67.20% | +117.59% | +158.79% | +351.03% | 16.08B | |
| +0.04% | -5.65% | -1.83% | +20.81% | +4.45% | +55.67% | +181.20% | +61.26% | - | 15.61B | |
| -1.10% | +2.95% | +47.63% | +10.62% | -9.19% | -6.59% | +789.32% | +503.25% | +6,261.56% | 15.47B | |
| -1.07% | -3.25% | +11.83% | +28.62% | +12.13% | +15.82% | -25.46% | -12.73% | -28.57% | 13.04B | |
| +1.22% | -2.09% | -5.97% | -5.03% | +18.41% | +98.02% | +212.30% | +928.88% | +2,866.67% | 11.19B | |
| +1.04% | +1.25% | -5.39% | +9.61% | +36.18% | +123.42% | +185.00% | +494.95% | - | 9.83B | |
| +4.93% | -0.38% | +32.56% | +153.02% | +292.21% | +342.43% | +568.15% | +27.81% | - | 7.44B | |
| -0.47% | -1.86% | +8.11% | +7.94% | -8.28% | -21.46% | -27.46% | -51.80% | -49.02% | 6.86B | |
| -1.01% | +6.50% | +6.95% | +31.27% | +9.03% | +18.75% | +78.37% | -3.89% | - | 6.62B | |
| +0.81% | +3.92% | -4.48% | +6.26% | +18.76% | +36.23% | +276.31% | +251.79% | - | 6.43B | |
| +3.17% | +3.46% | +23.82% | +40.12% | +91.95% | +137.21% | +383.39% | +541.65% | - | 5.99B | |
| Average | +1.88% | -0.09% | +9.06% | +24.87% | +35.18% | +57.58% | +163.96% | +156.29% | +976.57% | 23.16B | |
| Weighted average by Cap. | +2.50% | -0.18% | +10.02% | +20.48% | +17.91% | +35.00% | +94.00% | +80.41% | +525.84% |
- Stock Market
- Stocks
- BIIB Stock
- BIIB34 Stock
- Sector Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
